BBOT
BridgeBio Oncology Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.09
-0.04 ▼ -0.44%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$9.09
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.5 | Insider Own | 45.56% | Shs Outstand | 0.08B | Perf Week | -12.76% |
| Market Cap | 0.73B | Forward P/E | - | EPS next Y | 0.02% | Insider Trans | - | Shs Float | 0.04B | Perf Month | -24.5% |
| Enterprise Value | 0.30B | PEG | - | EPS next Q | -0.52 | Inst Own | 53.38% | Short Float | 5.34% | Perf Quarter | -29.43% |
| Income | -0.08B | P/S | - | EPS this Y | 49.61% | Inst Trans | 1.59% | Short Ratio | 8.17 | Perf Half Y | -10.62% |
| Sales | 0.00B | P/B | 1.77 | EPS next 5Y | 20.85% | ROA | -25.83% | Short Interest | 2.33M | Perf YTD | -27.4% |
| Book/sh | 5.14 | P/C | 1.71 | EPS past 3/5Y | -2681.49% -572.84% | ROE | -27.72% | 52W High | -38.87% ($14.87) | Perf Year | -15.76% |
| Cash/sh | 5.32 | P/FCF | - | Sales past 3/5Y | - | ROIC | -20.11% | 52W Low | 6.94% ($8.50) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -562.67% | Gross Margin | - | Volatility(W/M) | 5.91% 6.52% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.71 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.34 | EPS Q/Q | -683.63% | Profit Margin | - | RSI (14) | 34.58 | Recom | 1.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.34 | Sales Q/Q | - | SMA20 | -10.35% ($10.14) | Beta | 0.43 | Target Price | $25.38 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | -18.8% ($11.19) | Rel Volume | 0.67 | Prev Close | $9.13 |
| Employees | 92 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 22.6% - | SMA200 | -18.75% ($11.19) | Avg Volume(3M) | 0.28M | Price | $9.09 |
| IPO | 2024/2/9 | Option/Short | No/Yes | Trades | 2242 | Volume | 191,896 | Change | -0.44% |
뉴스 로딩 중...